Benjamin L Palleiko's Net Worth
$2.79 Million
Who is Benjamin L Palleiko?
Benjamin L Palleiko has an estimated net worth of $2.79 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., ORE PHARMACEUTICAL HOLDINGS INC., and PENWEST PHARMACEUTICALS CO.
SEC CIK
Benjamin L Palleiko's CIK is 0001366244
Past Insider Trading and Trends
2023 was Benjamin L Palleiko's most active year for acquiring shares with 6 total transactions. Benjamin L Palleiko's most active month to acquire stocks was the month of April. 2023 was Benjamin L Palleiko's most active year for disposing of shares, totalling 15 transactions. Benjamin L Palleiko's most active month to dispose stocks was the month of January. 2006 saw Benjamin L Palleiko paying a total of $2,590,590.00 for 151,000 shares, this is the most they've acquired in one year. In 2021 Benjamin L Palleiko cashed out on 59,284 shares for a total of $995,561.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.52
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +17.74% | 28.23K |
$14.11 | -$321,845.67 | 187.31K |
Feb 17 - Feb 20
| |||
Form 4
| -20.43% | -40.85K |
$15.01 | -$613,204.95 | 159.09K |
Feb 14
| |||
Form 4
| +77.82% | 87.5K |
—
|
—
| 199.94K |
Feb 11
| |||
Form 4
| +18.05% | 17.19K |
$8.23 | -$107,046.73 | 112.44K |
Nov 17 - Nov 20
| |||
Form 4
| +21.92% | 17.13K |
$10.73 | -$140,191.92 | 95.25K |
Aug 17 - Aug 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +7.32% | 5.33K |
$10.14 | -$40,952.94 | 78.13K |
Jan 11 - May 18
| |||
Form 4
| +6.45% | 4.41K |
$7.66 | -$37,947.64 | 72.8K |
Feb 17
| |||
Form 4
| +2.54% | 1.7K |
$5.44 | -$3,927.68 | 68.39K |
Nov 17 - Nov 18
| |||
Form 4
| +2.60% | 1.69K |
$14.96 | -$10,846.58 | 66.69K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
$20.17 | -$795,774.74 | 65K |
Scheduled
|
Feb 23
| ||
Form 4
| +100.00% | 32.5K |
—
|
—
| 65K |
Feb 7
| |||
Form 4
|
—
|
0
|
$13.39 | -$4,761.87 | 32.5K |
Scheduled
|
Dec 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
$16.76 | -$54,964.39 | 32.5K |
Apr 18 - Apr 22
| |||
Form 4
|
∞
| 32.5K |
—
|
—
| 32.5K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ORE PHARMACEUTICAL HOLDINGS INC. No price found
SVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PENWEST PHARMACEUTICALS CO No price found
SVP, Corporate Dev. & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +150.00% | 1.5K |
$10.87 | $16,305.00 | 2.5K |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 1K |
$18.09 | $18,090.00 | 1K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||